News

Client News Domainex wins award to develop GPCR drug discovery technology 23rd January 2018 Client News Synpromics Appoints Sarah Haecker Meeks, PhD as Vice President of Business Development Company establishes U.S. subsidiary to expand operations 17th January 2018 Client News Cypralis and Gilead Sciences, Inc. agree on license terms under which Cypralis will hold exclusive development and commercialization rights to certain jointly-owned ‘cyprolides’ for acute and chronic degenerative diseases 8th January 2018 Client News Client News Festival of Genomics London 2018: the landmark event making genomics mainstream 5th January 2018 Client News Client News Genome Engineering and Synthetic Biology – Sneak peek inside January’s conference programme 3rd January 2018 Client News Global Healthcare Investor Perception Report to be launched at Biotech and Money / Medtech and Money World Congress. 14th December 2017 Client News Client News Amyndas Pharmaceuticals Announces Positive Results from a Phase I Trial of its new complement C3 inhibitor AMY-101 13th December 2017 Client News Medherant completes £3.8 million funding round 11th December 2017 Client News Domainex appoints Chris Brown as Chief Financial Officer 6th December 2017 Client News New study shows European biotech companies returning greater investment value than US peers 28th November 2017